Tag: Transverse Medical

Transverse Medical Inc. Announces Completion of First Series of Patients in Feasibility Clinical Study at Victorian Heart Hospital, Melbourne, Australia, Using Point-Guard Cerebral Embolic Protection.

Coronary/Structural Heart by 0 comments

DENVER–(BUSINESS WIRE)–Transverse Medical Inc. is excited to announce the completion of the first series of patients under its Feasibility Clinical Study at the prestigious Victorian Heart Hospital in Melbourne, Australia. The patients undergoing TAVR procedures (Transcatheter Aortic Valve Replacement) were treated using the company’s next generation POINT-GUARD™ Cerebral Embolic Protection […]

Continue Reading →

Transverse Medical Appoints Former Boston Scientific EVP and Global Chief Medical Officer, Professor Ian T. Meredith, to Board of Directors

Financial by 0 comments

DENVER–(BUSINESS WIRE)–Transverse Medical, Inc., developer of the POINT-GUARD™ Cerebral Embolic Protection medical device, is pleased to announce the appointment of Ian T. Meredith, MD to the Board of Directors. Professor Meredith brings over 35 years of experience and global leadership in cardiology coupled with successful clinical trials and device commercialization […]

Continue Reading →

Transverse Medical Appoints David C. Blowers to Board of Directors, Dr. Rahul Sharma as Independent Member, Carl St. Bernard rejoins Board.

Financial by 0 comments

DENVER–(BUSINESS WIRE)–Point-Guard Protected™ Safeguard the Brain, Treat the Heart. Transverse Medical, Inc., developer of the POINT-GUARD™ Cerebral Embolic Protection medical device to protect the patient from stroke during Transcatheter Aortic Valve Replacement (TAVR) has reorganized the Board of Directors following the recent closing of a Series B1 financing. Transverse Medical […]

Continue Reading →